IRTC NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

iRhythm Technologies Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 117.2 USD
7.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -7.5% below the Trend Line and sits at 14.7% of its 52-week range. The latest completed week returned 7.3%, after a -7.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: earnings are due in 4d.

Setup score 26 out of 100
Latest Close 117.2 USD 31 Jul 2026
1W Return 7.3% latest completed week
4W Return -7.4% short-term follow-through
12W Return -2.9% quarterly tape
Trend Breadth 46.2% 24 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Next-week expectancy is negative at 40.79% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.3% Latest completed week; four-week move -7.4%. Indicator stack 25/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.79% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 52/100 conviction; expected move 12.6%. News sentiment 50/100 68 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -7.5% below the Trend Line and sits at 14.7% of its 52-week range. The latest completed week returned 7.3%, after a -7.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0712-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.4% over four weeks, -2.9% over 12 weeks, and -29.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W7.3%
4W-7.4%
12W-2.9%
26W-24.2%
52W-29.0%
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.36Latest activity-pressure read.
Pressure change-32.6%Four-week change in activity pressure.
Leadership-27.94Latest relative-leadership reading.
RS change-3.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value7/100Relative valuation strength. Underlying universe rank 94; rank 1 is best.
Quality28/100Profitability and accounting quality. Underlying universe rank 73; rank 1 is best.
Momentum18/100Medium-term price momentum. Underlying universe rank 83; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4.6x
Market value relative to trailing revenue.
EV / EBITDA
323.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
71.0%
Gross profit retained from each unit of revenue.
Operating margin
-1.8%
Operating profit retained from revenue.
Free-cash-flow margin
13.5%
Free cash flow generated from revenue.
Return on invested capital
-1.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
27.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
31.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.3%
Net share repurchases relative to market value.
Shareholder yield
-0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
38.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

IRTC shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 12.6%, and Sharemaestro trend signal inactive.

Conviction53/100
Expected move12.6%
Put/call volume0.00
Pressure100
Speculation9
Volatility86
Trend agreement0
Open options detail
Insider activity13 / 7

13 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 68 relevant articles.

17 positive · 38 neutral · 13 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move12.6%Nearest-chain priced movement where available.
52-week drawdown-44.7%Distance below the 52-week high.
13-week volatility6.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+13.6%Week of 26 Jun.
Worst week-11.4%Week of 27 Feb.
Latest week+7.3%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks0
Modest losses8
Sharp losses9
Recent vol6.4%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape26/100

Trend, activity pressure, participation, and risk combine to a 26/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 40.79%

Next-week expectancy is negative with a 40.79% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors13/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74; Small Cap Core rank 98 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options36/100

IRTC shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 12.6%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 12.6% Sentiment50/100

Weighted news tone is neutral across 68 relevant articles.

Precision Trading with Irhythm Technologies Inc. (IRTC) Risk Zones Insiders13 / 7

13 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026117.2 USD7.3%126.6 USD116.7 USD0.36-27.943.0MOff
24 Jul 2026109.2 USD-1.5%128.6 USD116.6 USD0.38-33.171.7MOff
17 Jul 2026110.9 USD-4.5%130.8 USD116.6 USD0.69-33.642.7MOff
10 Jul 2026116.1 USD-8.2%132.9 USD116.6 USD0.65-33.843.3MOff
3 Jul 2026126.5 USD6.4%134.7 USD116.5 USD0.53-27.142.2MOff
26 Jun 2026118.9 USD13.6%136.4 USD116.3 USD0.34-31.353.8MOff
19 Jun 2026104.7 USD-7.9%138.7 USD116.2 USD0.03-42.812.5MOff
12 Jun 2026113.7 USD5.1%141.1 USD116.2 USD-0.02-36.902.3MOff
5 Jun 2026108.1 USD-5.1%143.0 USD116.1 USD-0.18-39.143.1MOff
29 May 2026113.9 USD-2.3%145.3 USD116.1 USD-0.28-39.342.2MOff
22 May 2026116.6 USD2.2%147.7 USD116.0 USD-0.33-36.692.5MOff
15 May 2026114.0 USD-5.5%149.8 USD116.0 USD-0.64-37.882.5MOff
8 May 2026120.7 USD-0.1%152.1 USD116.1 USD-0.94-35.003.0MOff
1 May 2026120.8 USD-1.3%154.0 USD116.1 USD-1.35-31.914.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.